September 8, 2021 09:04 AM EDT
Coronavirus

Covid-19 roundup: Gates Foun­da­tion, Ex­sci­en­tia team up on pan­dem­ic an­tivi­ral dis­cov­ery pact; No­vavax opens tri­al for coro­n­avirus/flu com­bo vac­cine

Kyle Blankenship

UK-based AI dis­cov­ery out­fit Ex­sci­en­tia has signed its name to a $70 mil­lion col­lab­o­ra­tion with the Bill and Melin­da Gates Foun­da­tion to drum up five …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times